Stay updated on ADP-A2M4CD8 in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the ADP-A2M4CD8 in Ovarian Cancer Clinical Trial page.

Latest updates to the ADP-A2M4CD8 in Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedSponsor/collaborator details changed from Adaptimmune to USWM CT, LLC and USWM, LLC (dba US WorldMeds). New sections Oversight, Sponsor/Collaborators, Study Status, and Study Identification were added, with updates dated February 2026.SummaryDifference1%

- Check34 days agoChange DetectedA new revision entry (v3.4.2) was added and an older revision/notice (v3.4.1) was removed. These are administrative changes and do not alter core study information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check41 days agoChange DetectedNotice about a lapse in government funding affecting site operations. The site revision was updated to v3.4.1, replacing v3.4.0.SummaryDifference0.8%

- Check48 days agoChange DetectedThe history page now shows UI annotations including a 'Show glossary' option, green highlights for additions, red highlights for deletions, and a new version label (Revision: v3.4.0). The older notes (No FEAR Act data, Revision: v3.3.4) are replaced by the new revision.SummaryDifference1%

- Check62 days agoChange DetectedRevision label on the Record History page changed from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ADP-A2M4CD8 in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADP-A2M4CD8 in Ovarian Cancer Clinical Trial page.